- Bevorzugter Name
- 4-O-(2,6-Diamino-2,6-dideoxy-alpha-D-glucopyranosyl)-5-O-[3-O-(2,6-diamino-2,6-dideoxy-alpha-D-glucopyranosyl)-beta-D-ribofuranosyl]-3-amino-2,3-dideoxy-D-myo-inositol
- IUPAC
- (2R,3S,4R,5R,6R)-5-amino-6-[(1R,2R,3S,4R,6S)-6-amino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6R)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3,4-dihydroxycyclohexyl]oxy-2-(aminomethyl)oxane-3,4-diol
- Englischer Name
- 4-O-(2,6-Diamino-2,6-dideoxy-α-D-glucopyranosyl)-5-O-[3-O-(2,6-diamino-2,6-dideoxy-α-D-glucopyranosyl)-β-D-ribofuranosyl]-3-amino-2,3-dideoxy-D-myo-inositol
- Summenformel
- C23H45N5O14
- Molmasse
- 615.63
Namen und Synonyme
Bu 2659BD-myo-Inositol, O-2,6-diamino-2,6-dideoxy-alpha-D-glucopyranosyl-(1-4)-O-(O-2,6-diamino-2,6-dideoxy-alpha-D-glucopyranosyl-(1-3)-beta-D-ribofuranosyl-(1-5))-3-amino-2,3-dideoxy-4-O-(2,6-Diamino-2,6-dideoxy-alpha-D-glucopyranosyl)-5-O-[3-O-(2,6-diamino-2,6-dideoxy-alpha-D-glucopyranosyl)-beta-D-ribofuranosyl]-3-amino-2,3-dideoxy-D-myo-inositolBMY-28163Inosamycin BAntibiotic BMY-281634-O-(2,6-Diamino-2,6-dideoxy-α-D-glucopyranosyl)-5-O-[3-O-(2,6-diamino-2,6-dideoxy-α-D-glucopyranosyl)-β-D-ribofuranosyl]-3-amino-2,3-dideoxy-D-myo-inositol
Datenbank-Bezeichner
- PubChem CID
- 13423454
- Nikkaji
- J122.642H